Position in ACLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$192,426,263
+$62,123,868 QoQ
Shares Held
1,675,895
-16.1% QoQ
Ownership
2.87%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 14%
Shared 0%
None 86%
Common Shares in ACLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,288,856,014 across 423 Biotechnology names. ACLX ranks #32 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in ACLX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $192,426,263 | 1,675,895 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $130,302,395 | 1,998,503 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $125,286,816 | 1,526,027 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $104,853,811 | 1,592,313 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $109,319,185 | 1,666,451 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $136,153,278 | 1,775,372 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $129,017,855 | 1,544,939 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $96,895,096 | 1,755,664 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $131,109,956 | 1,885,118 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $98,448,064 | 1,773,839 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $72,271,110 | 2,014,245 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $61,082,409 | 1,931,765 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $57,751,989 | 1,874,456 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $50,066,499 | 1,616,091 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $28,418,249 | 1,514,025 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $3,178,771 | 175,817 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $995,490 | 71,005 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||